Graham R. Bignell connects Gene with Genetic linkage in his research. He brings together Genetic linkage and Genetics to produce work in his papers. Graham R. Bignell undertakes multidisciplinary investigations into Genetics and Pharmacogenomics in his work. He conducted interdisciplinary study in his works that combined Pharmacogenomics and Gene. While working on this project, Graham R. Bignell studies both Cancer and Signal transduction. He carries out multidisciplinary research, doing studies in Signal transduction and Cancer. Graham R. Bignell integrates Cancer research with Carcinogenesis in his study. Graham R. Bignell performs multidisciplinary study in the fields of Carcinogenesis and Cancer research via his papers. Graham R. Bignell combines Computational biology and Bioinformatics in his studies.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mutations of the BRAF gene in human cancer
Helen Davies;Graham R. Bignell;Charles Cox;Philip Stephens.
Nature (2002)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio.
Nature (2013)
Identification of the breast cancer susceptibility gene BRCA2
Wooster R;Bignell G;Lancaster J;Swift S.
Nature (1995)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman;Philip Stephens;Raffaella Smith;Gillian L. Dalgliesh.
Nature (2007)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett;Elena J. Edelman;Sonja J. Heidorn;Christopher Greenman;Christopher Greenman.
Nature (2012)
Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
Philip J. Stephens;Chris D. Greenman;Beiyuan Fu;Fengtang Yang.
Cell (2011)
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
A Hemminki;D Markie;I Tomlinson;E Avizienyte.
Nature (1998)
A comprehensive catalogue of somatic mutations from a human cancer genome
Erin D. Pleasance;R. Keira Cheetham;Philip J. Stephens;David J. Mcbride.
Nature (2010)
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik-Zainal;Ludmil B. Alexandrov;David C. Wedge;Peter Van Loo;Peter Van Loo;Peter Van Loo.
Cell (2012)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens;Patrick S. Tarpey;Helen Davies;Peter Van Loo;Peter Van Loo.
Nature (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Wellcome Sanger Institute
Wellcome Sanger Institute
Wellcome Sanger Institute
AstraZeneca (United Kingdom)
Wellcome Sanger Institute
University of Cambridge
Wellcome Sanger Institute
Wellcome Sanger Institute
Cardiff University
The University of Texas MD Anderson Cancer Center
Amazon (United States)
BI Norwegian Business School
Chinese Academy of Sciences
Hokkaido University
Leiden University
Tianjin University
Guilin University of Electronic Technology
Qingdao University
Australian Nuclear Science and Technology Organisation
Temple University
Monash University
Australian Catholic University
Harvard University
Columbia University
University of Copenhagen
National Institutes of Health